Low-Molecular Weight Heparin and Aspirin Provide Similar VTE Prevention in Trauma Fracture Patients
Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.PloS one. 2020 Aug 3;15(8):e0235628
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Three hundred and twenty-nine patients with a traumatic extremity fracture requiring operative treatment where venous thromboembolism prophylaxis was needed were randomized to receive either low-molecular weight heparin (LMWH) or aspirin. The primary outcome of interest included the incidence of mortality, bleeding, venous thromboembolism (VTE), deep surgical site infection, and a combination of t...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE